Varian Medical Systems Inc (VAR) Annual Income Statement

Annual · GAAP · USD millions
Access VAR quarterly income statements →
From Varian Medical Systems Inc through Sep 30 2016, changes in Oct 02 2020's revenue and cost structure provide insight into profitability trends.
Annual Report, GAAP in USD millions
ITEM
(Oct 02 2020)
2020
(Sep 27 2019) (Sep 28 2018) (Sep 29 2017) (Sep 30 2016)
Revenues
Sales Revenue, Services, Net0.00
Revenue From Contract With Customer Excluding Assessed Tax3,168.20
Total Revenue3,168.20
Costs & Expenses
Cost of Goods and Services Sold1,791.00
Gross Profit1,377.20
Selling, Administration, Marketing671.80
Research and Development Expense280.60
Restructuring, Settlement and Impairment Provisions77.00
Other exp. /-income0.00
Total operating costs including COS2,845.00
Operating income / -loss323.20
Interest Expense14.00
Net Interest Expense / -Income14.00
Investment Income, Interest0.00
Other loss/ -income-49.10
Total costs & expenses2,809.90
Income & Taxes
Income / -loss before income taxes358.30
Income taxes expenses / -benefit88.90
Income after income taxes269.40
Net income / -loss of other equity0.00
Income / -loss from continuing operations269.40
Discontinued operations0.00
Non-controlling interests358.50
Net income / -loss269.40
Income / -loss to shareholder269.20
EBIT372.30
EBITD433.90
EBITDA463.10
Earnings Per Share
Basic EPS (excl. extra items)2.96
Extraordinary items0.00
Basic Net EPS2.96
Basic shares outstanding (Mill. of Units)90.90
Diluted Net EPS2.94
Diluted average shares (Mill. of Units)91.50
4 historic quarters locked

Sign in to unlock the full Varian Medical Systems Inc income statement history.

About VAR Annual Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-K filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-K filings
  • Filed with the SEC: n/a

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.